z-logo
open-access-imgOpen Access
Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+ and CD4+ T Cell Functionality
Author(s) -
Shivan Chetty,
Pamla Govender,
Jennifer Zupkosky,
Manormoney Pillay,
Musie Ghebremichael,
Mahomed-Yunus S. Moosa,
Thumbi Ndung’u,
Filippos Porichis,
Victoria Kasprowicz
Publication year - 2015
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0118654
Subject(s) - mycobacterium tuberculosis , tuberculosis , virology , human immunodeficiency virus (hiv) , coinfection , microbiology and biotechnology , cd8 , biology , aids related opportunistic infections , medicine , immunology , immune system , sida , viral disease , pathology
The ability of antigen-specific T cells to simultaneously produce multiple cytokines is thought to correlate with the functional capacity and efficacy of T cells. These ‘polyfunctional’ T cells have been associated with control of HIV. We aimed to assess the impact of co-infection with Mycobacterium tuberculosis (MTB) on HIV-specific CD8+ and CD4+ T cell function. We assessed T cell functionality in 34 South African adults by investigating the IFN-y, IL-2, TNF-α, IL-21 and IL-17 cytokine secretion capacity, using polychromatic flow cytometry, following HIV Gag-specific stimulation of peripheral blood mononuclear cells. We show that MTB is associated with lower HIV-specific T cell function in co-infected as compared to HIV mono-infected individuals. This decline in function was greatest in co-infection with active Tuberculosis (TB) compared to co-infection with latent MTB (LTBI), suggesting that mycobacterial load may contribute to this loss of function. The described impact of MTB on HIV-specific T cell function may be a mechanism for increased HIV disease progression in co-infected subjects as functionally impaired T cells may be less able to control HIV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here